Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.42.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.42.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.42.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.348ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.348ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.348ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.348NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.428.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.428.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.428.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.428.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AJ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AJ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AJ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AJ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.459ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.459ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.459ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.459NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.29ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.29NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.415.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.415.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.415.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.415.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.243.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.243.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.243.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.243.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.98ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.98ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.98ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.98NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.566ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.566ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.566ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.566NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.480ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.480ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.480ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.480NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.579ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.579ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.579ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.579NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
N.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
N.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
N.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used